New from the Carcinoid Cancer Foundation

NET NEWS (Winter-Spring 2006, Volume 1, Issue 1)

Many people may not be aware of all the various activities in which the Carcinoid Cancer Foundation is involved. This first newsletter enumerates CCF's role in patient advocacy, research, and dissemination of medical information and gives a summary of accomplishments in the year 2005 and plans for the year 2006.

You can access this newsletter either from the Newsworthy site or directly.

Monica Warner MS, RD CDN
Research Coordinator and Director of Development
Carcinoid Cancer Foundation, Inc.

The Role of Sandostatin in Treating Carcinoid Cancer

The role of Sandostain in treating Carcinoid Cancer and related Neuroendocrine Cancers will be the focus of the March 12th meeting of PCCAN. Wendy King of Novartis, the maker of Sandostatin, is our guest speaker. The meeting will be held from 2 pm to 4 pm, in dining room A at Hershey Medical Center.

Please RSVP for the meeting with PCCAN at CarcinoidSupport@juno.com or at 717-576-5095.